Preclinical studies using transgenic mice expressing human CD19 have shown that pre-B cells and their malignant counterparts, as well as pre-existing antibody-producing and autoantibody-producing ...
Institute for Advanced Optics, Hunan Institute of Science and Technology, Yueyang, Hunan 414006, China School of Information Science & Technology, Hunan Institute of Science and Technology, Yueyang, ...
Objectives: To evaluate feasibility and safety of CD19 directed CAR T cell therapy in three patients with systemic sclerosis (SSc) not qualifying for autologous stem cell transplantation (HSCT) ...